|1.||Rautenbach, Marina: 3 articles (07/2014 - 06/2007)|
|2.||Vosloo, Johan Arnold: 2 articles (07/2014 - 10/2013)|
|3.||Delattin, Nicolas: 1 article (07/2014)|
|4.||Troskie, Anscha Mari: 1 article (07/2014)|
|5.||Thevissen, Karin: 1 article (07/2014)|
|6.||Cammue, Bruno P A: 1 article (07/2014)|
|7.||Dathe, Margitta: 1 article (07/2014)|
|8.||Spathelf, Barbara M: 1 article (10/2013)|
|9.||Leussa, Adrienne N-N: 1 article (10/2013)|
|10.||Stander, Marietjie A: 1 article (10/2013)|
10/01/2013 - "Previous work by our group illustrated that the more polar tyrocidines rich in Trp residues in their structure were more active toward Gram-positive bacteria, while the more non-polar tyrocidines rich in Phe residues had greater activity toward Plasmodium falciparum, one of the major causative pathogens of malaria in humans. "
06/01/2007 - "We have isolated the major components of tyrothricin, cyclic decapeptides collectively known as the tyrocidines, and tested them against the human malaria parasite Plasmodium falciparum using standard in vitro assays. "
06/01/2007 - "Inhibition of malaria parasite blood stages by tyrocidines, membrane-active cyclic peptide antibiotics from Bacillus brevis."
|3.||Anti-Bacterial Agents (Antibiotics)